5-(tryptophylamino)-1,3-dioxoperhydropyrido[1,2-c]pyrimidine-based cholecystokinin receptor antagonists: reversal of CCK1 receptor subtype selectivity toward CCK2 receptors.

Source:http://linkedlifedata.com/resource/pubmed/id/15456276

J. Med. Chem. 2004 Oct 7 47 21 5318-29

Download in:

View as

General Info

PMID
15456276